Friday, May 10th, 2024

 

This symposium will provide an update on the latest developments in the management of sarcomas and leukemias including immunotherapy and CAR T-cell therapy. The program will review the indications for CART therapy as well as the toxicities of such therapy. The faculty — including leading experts from the top local and national cancer care institutions — will review the latest technologies and therapeutic approaches to challenging clinical problems and will focus on evidence-based approaches to the special physical, emotional and psychological needs of pediatric cancer patients and their families.

Working in partnership to provide the best possible care for the communities they serve, two local leaders in healthcare – Miami Cancer Institute, part of Baptist Health, the area's largest, not-for-profit healthcare provider, and not for profit Nicklaus Children's Hospital, part of Nicklaus Children's Health System and the leading provider of children's healthcare services in South Florida – are collaborating to improve healthcare through continuing education.

MORE INFORMATION AND REGISTER >>

Learning Objectives

Upon completion of this symposium, participants should be better able to:

• Initiate appropriate referral for CAR T-cell therapy.
• Assess indications of CAR T-cell toxicities.
• Implement necessary treatment plans to improve patient outcomes.
• Assess sarcoma frontline and relapse treatment.